The Role of Cdo1 in Ferroptosis and Apoptosis in Cancer

Area of Science:

• Biochemistry
• Molecular Biology
• Cancer Research

Background:

• Cysteine dioxygenase type 1 (Cdo1) is a tumor suppressor gene involved in cysteine metabolism and cellular antioxidant capacity.
• Altered Cdo1 function is observed in many cancers, highlighting its role in cancer cell survival.
• Cdo1's tumor suppressor role is considered mild, with promoter methylation being a common mutation.

Purpose of the Study:

• To review the current knowledge on apoptosis, ferroptosis, and the function of Cdo1 in cancer.
• To explore therapeutic strategies that leverage Cdo1's anticancer properties.
• To investigate the potential of targeting Cdo1 in cancer treatment, especially in neoadjuvant therapy.

Main Methods:

• Literature review compiling information on Cdo1, apoptosis, and ferroptosis.
• Analysis of Cdo1's role in regulating antioxidant levels and cell death pathways.
• Exploration of genetic and epigenetic alterations affecting Cdo1 function.

Main Results:

• Cdo1 promotes ferroptosis by reducing antioxidants, leading to cell membrane autoperoxidation via Fenton reactions.
• Cdo1 promotes apoptosis through cysteine metabolism products like taurine and low antioxidant levels.
• Cdo1's mild anticancer role suggests potential for therapeutic exploitation.

Conclusions:

• Targeting Cdo1 could be a promising strategy for developing new cancer therapies.
• Cdo1-targeting drugs may be beneficial in neoadjuvant therapies to combat anti-cancer drug resistance.
• Further research into Cdo1's mechanisms could unlock its full therapeutic potential in oncology.